Month: January 2026

Pomelo Care Raises $92 Million Series C, Reaches $1.7 Billion Valuation, to Expand Its Proven Model Beyond Maternity & Set a New National Standard for Women’s and Children’s Healthcare

Tivic Announces Special Webcast To Discuss Its Recent Acquisition of CDMO Assets – Highlighting Near-Term Strategic Potential and Immediate Contributions to Accelerated Drug Development Timelines

ALX Oncology Advances Separate Clinical Trials Evaluating Investigational CD47-Inhibitor Evorpacept and Novel EGFR-Targeted Antibody-Drug Conjugate ALX2004

- First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s choice of chemotherapy...

error: Content is protected !!